Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Boya Biology
Boya Biology
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Boya Biology
Stock Price
¥31.5
2024-10-29
Market Capitalization
¥15.5 B
2024-10-29
Revenue
¥2 B
FY, 2025
Boya Biology Summary
Company Summary
Overview
Boya Biology (华润博雅生物制药集团股份有限公司, also known as China Resources Boya Biopharmaceutical Group) is a company that offers pharmaceutical products. It offers biochemical drugs, chemical drugs, raw materials, and other pharmaceutical solutions.
Type
Public
Status
Active
Founded
1993
HQ
Fuzhou Shi, CN
|
view all locations
Website
https://www.china-boya.com/
Cybersecurity rating
ESG rating
40-49 out of 100
|
View all ESG data
Sectors
Healthcare
drug monitoring
pharmacy
Homepage
Linkedin
Table of Contents
Locations
Financials
Competitors
Locations
View all
1 location detected
Fuzhou Shi, Jiangxi Sheng
HQ
China
333 Huiquan Rd, Linchuan Qu
Boya Biology Financials
Summary Financials
Revenue (Q1, 2026)
¥316.1M
Gross profit (Q1, 2026)
¥143.5M
Net income (Q1, 2026)
¥30.0M
Cash (Q1, 2026)
¥821.7M
EBIT (Q1, 2026)
¥22.0M
Enterprise value
$14.9B
Competitors and Similar Companies
Pro-Pharma
Healthcare - Private
Cipla Medpro
Healthcare - Subsidiary
Ewopharma
Healthcare - Private
Glowderma
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top